COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study.
Federico MontiniAgostino NozzolilloNicolò TedoneDamiano MistriPaola Mv RancoitaChiara ZanettaAlessandra MandelliRoberto FurlanLucia MoiolaVittorio MartinelliMaria Assunta RoccaMassimo Filippinull nullPublished in: Journal of neurology, neurosurgery, and psychiatry (2023)
In PwMS, COVID-19 has no impact on disease activity, course and cognitive performance 18-24 months after infection.